Sonendo, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

Shareholding (Dec 2024)

FII

0.24%

Held by 3 FIIs

DII

94.78%

Held by 5 DIIs

Promoter

0.21%

How big is Sonendo, Inc.?

22-Jun-2025

As of Jun 17, Sonendo, Inc. has a market capitalization of 0.49 million, with net sales of 31.70 million and a net profit of -33.55 million over the latest four quarters. Shareholder's funds are reported at 5.19 million, and total assets amount to 31.27 million.

What does Sonendo, Inc. do?

22-Jun-2025

Sonendo, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $8 million and a net loss of $6 million as of December 2024. Key metrics include a market cap of $0.49 million, a debt-to-equity ratio of 0.75, and a return on equity of -614.16%.

Is Sonendo, Inc. overvalued or undervalued?

20-Sep-2025

As of May 10, 2022, Sonendo, Inc. is considered risky and overvalued due to negative financial ratios, with a current price of $0.25 significantly lower than its 52-week high of $11.74, indicating challenges in attracting investor confidence compared to industry peers.

Is Sonendo, Inc. technically bullish or bearish?

20-Sep-2025

As of July 7, 2025, Sonendo, Inc. shows a mildly bearish trend with mixed indicators, including mildly bullish MACD signals but bearish daily moving averages and KST, suggesting potential resistance and no clear trend.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 0 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.75

Return on Equity

-614.16%

Price to Book

0.00

Revenue and Profits:

Net Sales:

8 Million

(Quarterly Results - Dec 2024)

Net Profit:

-6 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

464.1%

6 Months

-83.21%

1 Year

-92.11%

2 Years

-99.18%

3 Years

-90.6%

4 Years

-99.99%

5 Years

-97.95%

Sonendo, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Sonendo, Inc. technically bullish or bearish?

As of 7 July 2025, the technical trend for Sonendo, Inc. has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the weekly and monthly Bollinger Bands are both mildly bearish, suggesting potential resistance. The daily moving averages are bearish, and the KST shows a bearish signal on both weekly and monthly time frames. The Dow Theory indicates no trend on a weekly basis and is bearish monthly. The monthly RSI is bullish, but the weekly RSI shows no signal. Overall, the indicators present a mixed picture, leaning towards a mildly bearish stance. There is no available return data to compare the company's performance against the S&P 500....

Is Sonendo, Inc. overvalued or undervalued?

As of 10 May 2022, the valuation grade for Sonendo, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued, given its significant negative ratios, including a Price to Book Value of 0.10, an EV to EBIT of -0.16, and an EV to EBITDA of -0.17. These metrics suggest that the market is not valuing the company favorably compared to its peers. In comparison to its industry, Sonendo's valuation ratios are concerning, especially when looking at peers like Delcath Systems, Inc., which has a P/E ratio of 68.06, and iCAD, Inc., which has a P/E ratio of -19.65. The stark contrast in valuations highlights the challenges Sonendo faces in attracting investor confidence. Although return data is not available for a direct comparison with the S&P 500, the company's current price of $0.25, significantly lower than its 52-wee...

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-35.51%

EBIT Growth (5y)

-195.03%

EBIT to Interest (avg)

-7.25

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.75

Sales to Capital Employed (avg)

0.74

Tax Ratio

0.01%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

42.53%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.10

EV to EBIT

-0.16

EV to EBITDA

-0.17

EV to Capital Employed

0.49

EV to Sales

0.14

PEG Ratio

Dividend Yield

ROCE (Latest)

-304.92%

ROE (Latest)

-614.16%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2024

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 7 Schemes (4.78%)

Foreign Institutions

Held by 3 Foreign Institutions (0.24%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -29.06% vs -4.10% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 41.28% vs 0.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.30",
          "val2": "11.70",
          "chgp": "-29.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.70",
          "val2": "-9.20",
          "chgp": "48.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "1.00",
          "chgp": "-10.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "-0.30",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.40",
          "val2": "-10.90",
          "chgp": "41.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-606.60%",
          "val2": "-821.20%",
          "chgp": "21.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -8.38% vs -17.03% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 46.40% vs -9.46% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.70",
          "val2": "34.60",
          "chgp": "-8.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-27.10",
          "val2": "-53.70",
          "chgp": "49.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.50",
          "val2": "6.50",
          "chgp": "-15.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-2.60",
          "chgp": "69.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-33.50",
          "val2": "-62.50",
          "chgp": "46.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-901.10%",
          "val2": "-1,636.40%",
          "chgp": "73.53%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY

Dec'24

Dec'23

Change(%)

Net Sales

8.30

11.70

-29.06%

Operating Profit (PBDIT) excl Other Income

-4.70

-9.20

48.91%

Interest

0.90

1.00

-10.00%

Exceptional Items

-0.60

-0.30

-100.00%

Consolidate Net Profit

-6.40

-10.90

41.28%

Operating Profit Margin (Excl OI)

-606.60%

-821.20%

21.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2024 is -29.06% vs -4.10% in Dec 2023

Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 41.28% vs 0.00% in Dec 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

31.70

34.60

-8.38%

Operating Profit (PBDIT) excl Other Income

-27.10

-53.70

49.53%

Interest

5.50

6.50

-15.38%

Exceptional Items

-0.80

-2.60

69.23%

Consolidate Net Profit

-33.50

-62.50

46.40%

Operating Profit Margin (Excl OI)

-901.10%

-1,636.40%

73.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -8.38% vs -17.03% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 46.40% vs -9.46% in Dec 2023

All Annual Results

Company CV

About Sonendo, Inc.

Sonendo, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Sonendo, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Sonendo, Inc.?

Watch in Real-Time

What does Sonendo, Inc. do?

Is Sonendo, Inc. overvalued or undervalued?

Is Sonendo, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Sonendo, Inc. technically bullish or bearish?

Is Sonendo, Inc. overvalued or undervalued?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Sonendo, Inc.

Company Coordinates